Doctor profile · Federal record

Dr. Vikas Aurora, MD

Hematology & Oncology Physician (CMS: Hematology/Oncology) · Internal Medicine Physician · Grapevine, TX

  • NPI 1033309240
  • Accepts Medicare
  • MIPS 86.7 / 100 · 2023
  • 25 yrs in practice
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
1643 Lancaster Dr, 202
Grapevine, TX 760513593
(817) 251-9080
fax (817) 251-9082
Mailing address
Po Box 911230
Dallas, TX 753911230

Credentials & registration

NPPES · NUCC
NPI registered
July 2007 — 19 yrs on file
Profile last updated
November 12, 2021
Year of graduation
2001 — 25 yrs since
Specialty taxonomy
207RH0003X — NUCC code
State license (1)
Texas #M7018
Medicaid (3)
TX #188661601 · TX #188661603 · TX #188661602

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1033309240. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
33,981
Distinct HCPCS
10
Medicare allowed
$303,818
HCPCS Description Services Patients Avg allowed
Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) 12,240 18 $1
J1756 Injection, iron sucrose, 1 mg 8,600 16 $0
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 5,030 58 $0
85025 Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count 1,192 386 $8
80053 Blood test, comprehensive group of blood chemicals 1,158 384 $10
36415 Insertion of needle into vein for collection of blood sample 1,024 336 $8
99213 Established patient office or other outpatient visit, 20-29 minutes 558 342 $88
J1100 Injection, dexamethasone sodium phosphate, 1 mg 528 31 $0
83615 Lactate dehydrogenase (enzyme) level 283 131 $6
83540 Iron level 278 151 $6

In context: peer comparison

Among 1 peers in this city , average services per provider: 723. This provider delivers 47× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$2,204
Transactions
51
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Novartis Pharmaceuticals Corporation 13 $1,059.58
ABBVIE INC. 5 $213.25
Daiichi Sankyo Inc. 4 $103.50
Merck Sharp & Dohme LLC 4 $90.82
Gilead Sciences, Inc. 4 $81.13
PFIZER INC. 3 $68.85
Celgene Corporation 3 $67.17
Lilly USA, LLC 3 $57.54
AstraZeneca Pharmaceuticals LP 2 $54.64
E.R. Squibb & Sons, L.L.C. 2 $47.45
Bayer Healthcare Pharmaceuticals Inc. 2 $44.11
Janssen Biotech, Inc. 2 $39.49
Astellas Pharma US Inc 1 $33.46
Alexion Pharmaceuticals, Inc. 1 $32.77
GlaxoSmithKline, LLC. 2 $29.84

By nature of payment

Food and Beverage
$1,108
Long term medical supply or device loan
$997
Education
$99

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
605
Patients
83
Total drug cost
$616,415
Drug Type Claims Patients Total cost
Letrozole Generic 143 36 $5,358
Eliquis (Apixaban) Brand 76 19 $64,568
Xarelto (Rivaroxaban) Brand 52 11 $48,214
Warfarin Sodium Generic 45 0 $456
Hydroxyurea Generic 34 0 $1,250
Acyclovir Generic 32 0 $568
Imbruvica (Ibrutinib) Brand 31 0 $459,984
Dexamethasone Generic 30 17 $357
Anastrozole Generic 27 0 $733
Venlafaxine Hcl Er (Venlafaxine Hcl) Brand 25 0 $835

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Vikas Aurora's medical specialty?
Dr. Vikas Aurora practices Hematology & Oncology Physician in Grapevine, TX.
Where does Dr. Vikas Aurora practice?
Dr. Vikas Aurora practices at 1643 Lancaster Dr, Grapevine, TX 760513593. Office phone: 8172519080.
What is Dr. Vikas Aurora's NPI?
Dr. Vikas Aurora's National Provider Identifier (NPI) is 1033309240, issued by NPPES.
Does Dr. Vikas Aurora accept Medicare assignment?
Yes. Dr. Vikas Aurora accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Vikas Aurora commonly perform?
Top Medicare-reported procedures in 2023: Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) (HCPCS Q0138); Injection, iron sucrose, 1 mg (HCPCS J1756); Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS Q9967). Source: CMS Medicare Physician & Other Practitioners file.